Sweden
· Delayed Price · Currency is SEK Pila Pharma AB Statistics
Total Valuation
Pila Pharma AB has a market cap or net worth of SEK 89.52 million. The enterprise value is 84.62 million.
| Market Cap | 89.52M |
| Enterprise Value | 84.62M |
Important Dates
The next estimated earnings date is Wednesday, August 27, 2025.
| Earnings Date | Aug 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Pila Pharma AB has 27.13 million shares outstanding. The number of shares has increased by 20.66% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 27.13M |
| Shares Change (YoY) | +20.66% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 22.97% |
| Owned by Institutions (%) | 14.59% |
| Float | 11.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 113.33 |
| PB Ratio | 17.01 |
| P/TBV Ratio | 21.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.53 |
| EV / Sales | 107.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.21
| Current Ratio | 5.21 |
| Quick Ratio | 5.16 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2,631.13 |
Financial Efficiency
Return on equity (ROE) is -188.57% and return on invested capital (ROIC) is -85.02%.
| Return on Equity (ROE) | -188.57% |
| Return on Assets (ROA) | -69.05% |
| Return on Invested Capital (ROIC) | -85.02% |
| Return on Capital Employed (ROCE) | -154.13% |
| Revenue Per Employee | 789,889 |
| Profits Per Employee | -11.24M |
| Employee Count | 1 |
| Asset Turnover | 0.11 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +30.44% in the last 52 weeks. The beta is 0.65, so Pila Pharma AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | +30.44% |
| 50-Day Moving Average | 3.37 |
| 200-Day Moving Average | 4.47 |
| Relative Strength Index (RSI) | 43.11 |
| Average Volume (20 Days) | 23,181 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pila Pharma AB had revenue of SEK 789,889 and -11.24 million in losses. Loss per share was -0.44.
| Revenue | 789,889 |
| Gross Profit | 789,889 |
| Operating Income | -8.11M |
| Pretax Income | -11.24M |
| Net Income | -11.24M |
| EBITDA | -7.03M |
| EBIT | -8.11M |
| Loss Per Share | -0.44 |
Balance Sheet
The company has 4.89 million in cash and n/a in debt, giving a net cash position of 4.89 million or 0.18 per share.
| Cash & Cash Equivalents | 4.89M |
| Total Debt | n/a |
| Net Cash | 4.89M |
| Net Cash Per Share | 0.18 |
| Equity (Book Value) | 5.26M |
| Book Value Per Share | 0.19 |
| Working Capital | 4.05M |
Cash Flow
| Operating Cash Flow | -7.82M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -1,026.62% |
| Pretax Margin | -1,423.15% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Pila Pharma AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.66% |
| Shareholder Yield | -20.66% |
| Earnings Yield | -12.56% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Pila Pharma AB has an Altman Z-Score of 34.06.
| Altman Z-Score | 34.06 |
| Piotroski F-Score | n/a |